Sort   by:  
 Page size 
UnknownEarly loss of immunity against measles following allogeneic hematopoietic stem cell transplantation.
Not available
S-EPMC6771529 | biostudies-literature
UnknownPrimary SARS-CoV-2 variant of concern infections elicit broad antibody Fc-mediated effector functions and memory B cell responses.
Not available
S-EPMC11349224 | biostudies-literature
UnknownHigh titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophages.
Not available
S-EPMC8158960 | biostudies-literature
UnknownA Robust Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific T- and B-Cell Response Is Associated With Early Viral Clearance in SARS-CoV-2 Omicron-Infected Immunocompromised Individuals.
Not available
S-EPMC11481360 | biostudies-literature
UnknownA public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spike.
Not available
S-EPMC9352689 | biostudies-literature
UnknownPotent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability.
Not available
S-EPMC7299281 | biostudies-literature
UnknownTwo-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection.
Not available
S-EPMC7834972 | biostudies-literature
UnknownRisk of new HIV diagnosis by intersecting migration, socioeconomic, and mental health vulnerabilities in the Netherlands: a nationwide analysis of the ATHENA cohort and Statistics Netherlands registry data.
Not available
S-EPMC12765169 | biostudies-literature
UnknownSimilar Limited Protection Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Infection in Vaccinated Individuals With HIV and Comparable Controls.
Not available
S-EPMC11273239 | biostudies-literature
UnknownPrecise targeting of HIV broadly neutralizing antibody precursors in humans.
Not available
S-EPMC12313413 | biostudies-literature
Sort   by:  
 Page size